{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:48:34Z","timestamp":1793213314884,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12185-019-02623-z","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T16:44:19Z","timestamp":1552063459000},"page":"553-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series"],"prefix":"10.1007","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-0059","authenticated-orcid":false,"given":"Oren","family":"Pasvolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Zoref-Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn Revital","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Vaxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Leader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"2623_CR1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503\u201316.","journal-title":"Lancet"},{"key":"2623_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"2623_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","volume":"2013","author":"GE Janka","year":"2013","unstructured":"Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Progr. 2013;2013:605\u201311.","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"2623_CR4","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125:2908\u201314.","journal-title":"Blood"},{"key":"2623_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/10428194.2010.551153","volume":"52","author":"M Machaczka","year":"2011","unstructured":"Machaczka M, Vaktnas J, Klimkowska M, Hagglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma. 2011;52:613\u20139.","journal-title":"Leuk Lymphoma"},{"key":"2623_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1182\/bloodadvances.2017005561","volume":"1","author":"EJ Vick","year":"2017","unstructured":"Vick EJ, Patel K, Prouet P, Martin MG. Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy. Blood Adv. 2017;1:779\u201391.","journal-title":"Blood Adv"},{"key":"2623_CR7","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G, Histocyte S. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367\u201373.","journal-title":"Blood"},{"key":"2623_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.amjmed.2014.04.034","volume":"127","author":"S Riviere","year":"2014","unstructured":"Riviere S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, Fardet L. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127:1118\u201325.","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"2623_CR9","first-page":"530","volume":"85","author":"G Veerakul","year":"2002","unstructured":"Veerakul G, Sanpakit K, Tanphaichitr VS, Mahasandana C, Jirarattanasopa N. Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome. J Med Assoc Thai. 2002;85(Suppl 2):530\u201341.","journal-title":"J Med Assoc Thai"},{"key":"2623_CR10","first-page":"997","volume":"100","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg K, Nichols KE, Henter JI, Girschikofsky M, Greenwood T, Jordan M, Kumar A, Minkov M, La Rosee P, Weitzman S. Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte S: Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica. 2015;100:997\u20131004.","journal-title":"Haematologica"},{"key":"2623_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58\u201365.","journal-title":"Int J Hematol"},{"key":"2623_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.13462","volume":"170","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Muller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Langler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol. 2015;170:539\u201349.","journal-title":"Br J Haematol"},{"key":"2623_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/10428190009060325","volume":"38","author":"C Shimazaki","year":"2000","unstructured":"Shimazaki C, Inaba T, Nakagawa M. B-cell lymphoma-associated hemophagocytic syndrome. Leuk Lymphoma. 2000;38:121\u201330.","journal-title":"Leuk Lymphoma"},{"key":"2623_CR14","first-page":"96","volume":"40","author":"N Takahashi","year":"1999","unstructured":"Takahashi N, Nakahachi A. Clinicopathological characteristics of adult patients with lymphoma-associated hemophagocytic syndrome in Japan. Rinsho Ketsueki. 1999;40:96\u20138.","journal-title":"Rinsho Ketsueki"},{"key":"2623_CR15","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613\u201320.","journal-title":"Arthritis Rheumatol"},{"key":"2623_CR16","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/cncr.30084","volume":"122","author":"GN Tamamyan","year":"2016","unstructured":"Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang S, Abdelall W, Konoplev SN, Daver NG. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes. Cancer. 2016;122:2857\u201366.","journal-title":"Cancer"},{"key":"2623_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","volume":"93","author":"T Tsuji","year":"2014","unstructured":"Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014;93:821\u20136.","journal-title":"Ann Hematol"},{"key":"2623_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/ijlh.12334","volume":"37","author":"W Chen","year":"2015","unstructured":"Chen W, Zhang S, Zhang W, Yang X, Xu J, Qiu H, Zhang X, Li J. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2015;37:544\u201350.","journal-title":"Int J Lab Hematol"},{"key":"2623_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3346\/jkms.1998.13.1.77","volume":"13","author":"JE Kim","year":"1998","unstructured":"Kim JE, Kim CW, Park SH, Chi JG. Hemophagocytic syndrome associated with occult B-cell lymphoma: an autopsy case. J Korean Med Sci. 1998;13:77\u201380.","journal-title":"J Korean Med Sci"},{"key":"2623_CR20","first-page":"1275","volume":"16","author":"Y Chang","year":"2018","unstructured":"Chang Y, Cui M, Fu X, Han L, Zhang L, Li L, Li X, Sun Z, Wu J, Zhang X, Li Z, Nan F, Yan J, Sheng G, Zhang M. Lymphoma associated hemophagocytic syndrome: A single-center retrospective study. Oncol Lett. 2018;16:1275\u201384.","journal-title":"Oncol Lett"},{"key":"2623_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00277-014-2276-9","volume":"94","author":"W Jing-Shi","year":"2015","unstructured":"Jing-Shi W, Yi-Ni W, Lin W, Zhao W. Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause. Ann Hematol. 2015;94:753\u201360.","journal-title":"Ann Hematol"},{"key":"2623_CR22","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/cncr.30826","volume":"123","author":"N Daver","year":"2017","unstructured":"Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosee P, Kantarjian HM. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123:3229\u201340.","journal-title":"Cancer"},{"key":"2623_CR23","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","volume":"126","author":"Y Wang","year":"2015","unstructured":"Wang Y, Huang W, Hu L, Cen X, Li L, Wang J, Shen J, Wei N, Wang Z. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015;126:2186\u201392.","journal-title":"Blood"},{"key":"2623_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3346\/jkms.2008.23.3.439","volume":"23","author":"HJ Shin","year":"2008","unstructured":"Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, Yang DH, Kim HJ, Kim JG, Joo YD, Lee WS, Sohn CH, Lee EY, Cho GJ. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci. 2008;23:439\u201344.","journal-title":"J Korean Med Sci"},{"key":"2623_CR25","doi-asserted-by":"crossref","first-page":"LBA-3","DOI":"10.1182\/blood.V126.23.LBA-3.LBA-3","volume":"126","author":"M Jordan","year":"2015","unstructured":"Jordan M: A novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFN\u03b3) monoclonal antibody (mAb), NI-0501: first results from a Pilot Phase 2 study in children with primary HLH. Blood. 2015;126: LBA-3.","journal-title":"Blood"},{"key":"2623_CR26","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1182\/blood-2017-10-808543","volume":"130","author":"S Ehl","year":"2017","unstructured":"Ehl S. Etoposide for HLH: the limits of efficacy. Blood. 2017;130:2692\u20133.","journal-title":"Blood"},{"key":"2623_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/MCC.0000000000000135","volume":"20","author":"JI Salluh","year":"2014","unstructured":"Salluh JI, Soares M. ICU severity of illness scores: APACHE, SAPS and MPM. Curr Opin Crit Care. 2014;20:557\u201365.","journal-title":"Curr Opin Crit Care"},{"issue":"Suppl 5","key":"2623_CR28","doi-asserted-by":"publisher","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","volume":"26","author":"F d\u2019Amore","year":"2015","unstructured":"d\u2019Amore F, Gaulard P, Trumper L, Corradini P, Kim WS, Specht L, Bjerregaard Pedersen M, Ladetto M, Committee EG. Peripheral T-cell lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v108\u2013115.","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"2623_CR29","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, Walewski J, Andre M, Johnson PW, Pfreundschuh M, Ladetto M, Committee EG. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116\u2013125.","journal-title":"Ann Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02623-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02623-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02623-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:54:40Z","timestamp":1721062480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02623-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02623-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}